Dandong Fang

Dr. Dandong Fang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2025 in Shock
Verified
Journal Article
Closed access
KWKeke Wu
Keke Wu
YMYuliang Ma
Yuliang Ma
YWYuchen Wang
Yuchen Wang
RWRong Wei
Rong Wei
DFDandong Fang
Dandong Fang
WLWeiqin Li
Weiqin Li
Sepsis is a life-threatening condition characterized by multiple organ dysfunction resulting from a dysregulated host immune response to infection. Septic cardiomyopathy (SCM), one of the most severe complications of sepsis, manifests as myocardial tissue injury and functional impairment and serves as a primary contributor to mortality in septic patients. Macrophages, pivotal innate immune cells in the heart, are classified into distinct subsets based on their developmental origins and microenvironmental cues. The dual roles of macrophage subsets, mediating both injury and protection, during the pathogenesis of SCM remain under active investigation. This review delineates the heterogeneity of macrophage subsets in sepsis and their cardiac implications, with a focus on elucidating the molecular mechanisms underlying macrophage-mediated cardiac injury (e.g., secretion of myocardial depressant substances, inflammatory responses, induction of mitochondrial dysfunction, mediation of ferroptosis) and protective processes (e.g., anti-inflammatory responses, phagocytic repair). These insights aim to provide a theoretical foundation for developing targeted immunomodulatory therapies and precise interventions directed at the cardiac immune microenvironment.

12 September 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
HDHongbin Deng
Hongbin Deng
SCSi Cheng
Si Cheng
JFJiemei Fan
Jiemei Fan
HHHaibin Hao
Haibin Hao
DFDandong Fang
Dandong Fang
WAWang Qi Author
Wang Qi Author
The objective of our study was to verify the intervention effect of Bacillus amyloliquefaciens SC06 on NE by constructing a C. perfringens-induced intestinal damage mouse model. A total of 40 mice were randomly assigned to four treatments: CON (basal diet), CP (basal diet + C. perfringens), SC06 + CP (basal diet + SC06 + C. perfringens) and SC06 (basal diet + SC06). Our findings indicated that SC06 supplementation was effective in maintaining the integrity of the intestinal barrier, enhancing the antioxidant capacity of the intestine, reducing the generation of an inflammatory response, and suppressing enterocyte apoptosis in the presence of C. perfringens. Furthermore, SC06 supplementation enhanced the prefoliation of intestinal stem cells (ISC) and prompted their differentiation into goblet cells and Paneth cells. Moreover, our findings indicate that SC06 promotes the proliferation of C. perfringens-induced jejunum organoids and the expression of genes and proteins associated with ISC differentiation and regeneration. The mechanism by which SC06 modulates ISCs has been validated, and the results align with those obtained in vivo. In conclusion, the findings demonstrated that SC06 stimulates the proliferation and differentiation of ISCs through the activation of the Wnt/β-catenin signaling pathway, thereby accelerating epithelial regeneration and repair.